Supernus Pharm (SUPN)

3 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Biggest Movers in Manufacturing Stocks Now – ONS CLVS AFMD BELFB

By Portfolio Grader Dec 19, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – VCEL AUPH ONVO CC

By Portfolio Grader Dec 13, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Biggest Movers in Manufacturing Stocks Now – BIOA OCUL HAYN USAT

By Portfolio Grader Nov 18, 2016

The following stocks were moving the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – STRT RPRX RETA SUPN

By Portfolio Grader Nov 15, 2016

The following stocks were moving the Manufacturing sector today.

Supernus Pharmaceuticals Inc (SUPN) Stock Dips Despite Positive ADHD Data

By John Kilhefner, Senior Managing Editor, Lango Franchise Oct 11, 2016

Supernus Pharmaceuticals Inc (SUPN) was up as much as 2% before giving up its gains, despite posting positive top-line data for its ADHD drug. Here's why.

10 Pharmaceuticals Stocks to Buy Now

By Portfolio Grader Oct 7, 2016

10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Hottest Manufacturing Stocks Now – WGO DVAX SCYX BMRA

By Portfolio Grader Oct 3, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

11 Pharmaceuticals Stocks to Buy Now

By Portfolio Grader Sep 30, 2016

The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Hottest Manufacturing Stocks Now – EPZM FIT DMPI CRBP

By Portfolio Grader Sep 15, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

7 Biotech Stocks to Watch for Runaway Gains

By Dana Blankenhorn, InvestorPlace Contributor Jul 21, 2016

Biotech stocks are never a sure thing, but these seven companies do pack a payload of promise. Look toward large pipelines and pathways to profits.

Biggest Movers in Manufacturing Stocks Now – BLDP SPHS WVE CVO

By Portfolio Grader Jul 18, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Biggest Movers in Manufacturing Stocks Now – SPHS BSPM DGLY ACHN

By Portfolio Grader Jul 7, 2016

The following stocks were moving the Manufacturing sector today.

7 Small-Cap Stocks to Buy for Gigantic Growth

By Alyssa Oursler, InvestorPlace Contributor Oct 29, 2015

Looking for the best stocks to buy? Size is everything -- just in reverse. These small-cap stocks are expected to deliver massive returns in the coming months.

The Best and Worst Funds During the Market’s Meltdown

By Kent Thune, InvestorPlace Contributor Sep 9, 2015

In hindsight of the biggest market correction in years, we can gain insight from looking at the best and worst funds during the chaos.

7 High-Growth Healthcare Stocks DEMOLISHING the Market in 2015

By John Divine, InvestorPlace Assistant Editor Aug 4, 2015

If you're a fan of growth stocks and healthcare stocks ... well, these seven names would've done you well in 2015. A few of them could keep soaring.

Supernus Pharmaceuticals GAAP EPS of $0.02 beats by $0.04, revenue of $164.3M beats by $9.27M (NASDAQ:SUPN)

From Seeking Alpha Feb 27, 2024

Supernus Pharmaceuticals reported Q4 GAAP EPS of $0.02, beating estimates by $0.04. The company's revenue of $164.3M exceeded expectations by $9.27M.

Supernus Pharmaceuticals GAAP EPS of -$0.29 in-line, revenue of $153.88M beats by $10.49M (NASDAQ:SUPN)

From Seeking Alpha Nov 8, 2023

Supernus Pharmaceuticals beats revenue expectations, raises guidance for 2023 and sees a significant increase in adjusted operating earnings.

Supernus resubmits NDA for Parkinson's disease infusion device (SUPN)

From Seeking Alpha Oct 9, 2023

Supernus Pharmaceuticals has resubmitted its New Drug Application to the FDA for SPN-830, an apomorphine infusion device for Parkinson's disease. Read more here.

EU regulators warn pregnant women not to use topiramate (NYSE:JNJ)

From Seeking Alpha Sep 1, 2023

EU regulators have recommended that pregnant women avoid using topiramate over concerns it may raise the risk of their children having neurodevelopmental disorders. Read more here.

Despite 1 Major Headwind and Pricey Shares, This Stock Is Still a Buy

From The Motley Fool Jun 10, 2023

Supernus Pharmaceuticals' revenue mix is shifting, and it could soon have more sales on the way.

FDA Demands More Data for Supernus’ SPN-830 NDA Filing

From TipRanks Oct 10, 2022

Biopharmaceutical company Supernus (NASDAQ:SUPN) has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for its new drug app...

Supernus Pharm (SUPN)

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

7 Great Biotech Stocks to Buy and Hold Now

5 Strong Growth Stocks That Goldman Sachs Says Look Cheap

5 Sizzling Small-Cap Stocks to Buy Today

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Supernus Pharm (SUPN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SUPN Stock Predictions, Articles, and Supernus Pharm News

Subscriber Sign in